Nasacort (Triamcinolone Acetonide)

Triamcinolone Acetonide, the active ingredient in Nasacort, is a corticosteroid presented as a nasal spray for nasal use. It treats allergic rhinitis and seasonal nasal congestion in adults and children.

GNH USA supplies Nasacort as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nasacort (triamcinolone acetonide) is a nasal corticosteroid used to manage inflammatory conditions of the nasal passages.

Allergic rhinitis: reduces nasal inflammation, congestion and itching associated with pollen or allergen exposure. Seasonal nasal congestion: alleviates blockage and runny nose during seasonal changes. Non‑allergic rhinitis: improves airflow and decreases mucus production in irritant‑induced nasal symptoms.

Nasacort may cause local and systemic adverse reactions.

Common Side Effects: - Nasal irritation or burning sensation - Dryness of nasal passages - Epistaxis (nosebleeds) - Headache - Throat irritation or soreness - Altered taste or smell

Serious or Rare Side Effects: - Nasal septal perforation - Severe allergic reaction (anaphylaxis) - Vision changes or ocular pressure increase - Profound or persistent nosebleeds - Opportunistic fungal infection of nasal mucosa - Systemic adrenal suppression (rare with prolonged high‑dose use)

Before using Nasacort, consider the following safety measures.

Follow label instructions: use only as directed by a healthcare professional. Avoid use after recent nasal surgery or trauma: may impair healing. Consult physician if you have uncontrolled diabetes, glaucoma, or cataracts. Do not combine with other nasal corticosteroids without medical advice. Pregnancy and breastfeeding: discuss potential risks with your doctor. Store at room temperature: keep in the original container, protect from moisture and heat.

Nasacort can interact with other medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Systemic corticosteroids: increased risk of systemic glucocorticoid effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise local drug exposure. - Live vaccines: potential reduction in vaccine efficacy.

Moderate Interactions (Monitor Closely): - Antifungal azoles (e.g., itraconazole): may modestly increase nasal steroid levels. - Protease inhibitors (e.g., ritonavir): may affect metabolism. - Other nasal decongestants: may increase local irritation or blood pressure effects.